225430 — KMPharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapNeutral

Annual balance sheet for KMPharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,697	598	1,024	810	351
Net Total Accounts Receivable
Net Total Receivables	3,753	2,281	2,334	1,321	1,216
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9,846	6,345	5,982	4,717	3,770
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	25,009	22,325	21,183	21,096	20,415
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	52,676	51,281	50,555	48,973	46,393
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7,473	12,498	11,882	9,316	11,898
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	12,770	14,953	15,077	16,358	18,127
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	39,906	36,328	35,479	32,615	28,266
Total Liabilities & Shareholders' Equity	52,676	51,281	50,555	48,973	46,393
Total Common Shares Outstanding